메뉴 건너뛰기




Volumn 7, Issue 2, 2012, Pages 258-264

Reversibility of the effects of aliskiren in the renal versus systemic circulation

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALISKIREN; ANGIOTENSIN; ANGIOTENSIN II; CREATININE; RENIN;

EID: 84857186227     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.05870611     Document Type: Article
Times cited : (12)

References (20)
  • 1
    • 0036372173 scopus 로고    scopus 로고
    • Angiotensin II suppression in humans by the orally active renin inhibitor Alis-kiren (SPP100): Comparison with enalapril
    • Nussberger J, Wuerzner G, Jensen C, Brunner HR: Angiotensin II suppression in humans by the orally active renin inhibitor Alis-kiren (SPP100): Comparison with enalapril. Hypertension 39: E1-E8, 2002
    • (2002) Hypertension , vol.39
    • Nussberger, J.1    Wuerzner, G.2    Jensen, C.3    Brunner, H.R.4
  • 2
    • 60549087324 scopus 로고    scopus 로고
    • Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: A 12-month randomized, double-blind comparator trial with hydrochlorothiazide
    • Schmieder RE, Philipp T, Guerediaga J, Gorostidi M, Smith B, Weissbach N, Maboudian M, Botha J, van Ingen H: Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: A 12-month randomized, double-blind comparator trial with hydrochlorothiazide. Circulation 119: 417-425, 2009
    • (2009) Circulation , vol.119 , pp. 417-425
    • Schmieder, R.E.1    Philipp, T.2    Guerediaga, J.3    Gorostidi, M.4    Smith, B.5    Weissbach, N.6    Maboudian, M.7    Botha, J.8    van Ingen, H.9
  • 3
    • 14844363404 scopus 로고    scopus 로고
    • Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebolike tolerability in hypertensive patients
    • Gradman AH, Schmieder RE, Lins RL, Nussberger J, Chiang Y, Bedigian MP: Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebolike tolerability in hypertensive patients. Circulation 111: 1012-1018, 2005
    • (2005) Circulation , vol.111 , pp. 1012-1018
    • Gradman, A.H.1    Schmieder, R.E.2    Lins, R.L.3    Nussberger, J.4    Chiang, Y.5    Bedigian, M.P.6
  • 4
    • 44849114597 scopus 로고    scopus 로고
    • AVOID Study Investigators: Aliskiren combined with losartan in type 2 diabetes and nephropathy
    • Parving HH, Persson F, Lewis JB, Lewis EJ, Hollenberg NK; AVOID Study Investigators: Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med 358: 2433-2446, 2008
    • (2008) N Engl J Med , vol.358 , pp. 2433-2446
    • Parving, H.H.1    Persson, F.2    Lewis, J.B.3    Lewis, E.J.4    Hollenberg, N.K.5
  • 5
    • 79958249630 scopus 로고    scopus 로고
    • Aliskiren Observation of Heart Failure Treatment (ALOFT) Investigators: Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure
    • McMurray JJ, Pitt B, Latini R, Maggioni AP, Solomon SD, Keefe DL, Ford J, Verma A, Lewsey J; Aliskiren Observation of Heart Failure Treatment (ALOFT) Investigators: Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure. Circ Heart Fail 1: 17-24, 2008
    • (2008) Circ Heart Fail , vol.1 , pp. 17-24
    • McMurray, J.J.1    Pitt, B.2    Latini, R.3    Maggioni, A.P.4    Solomon, S.D.5    Keefe, D.L.6    Ford, J.7    Verma, A.8    Lewsey, J.9
  • 7
    • 39849089447 scopus 로고    scopus 로고
    • Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: A 6-month, randomized, double-blind trial
    • Andersen K, Weinberger MH, Egan B, Constance CM, Ali MA, Jin J, Keefe DL: Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: A 6-month, randomized, double-blind trial. J Hypertens 26: 589-599, 2008
    • (2008) J Hypertens , vol.26 , pp. 589-599
    • Andersen, K.1    Weinberger, M.H.2    Egan, B.3    Constance, C.M.4    Ali, M.A.5    Jin, J.6    Keefe, D.L.7
  • 8
    • 33947182655 scopus 로고    scopus 로고
    • Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension
    • Oh BH, Mitchell J, Herron JR, Chung J, Khan M, Keefe DL: Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension. J Am Coll Cardiol 49: 1157-1163, 2007
    • (2007) J Am Coll Cardiol , vol.49 , pp. 1157-1163
    • Oh, B.H.1    Mitchell, J.2    Herron, J.R.3    Chung, J.4    Khan, M.5    Keefe, D.L.6
  • 10
    • 47049093197 scopus 로고    scopus 로고
    • Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans
    • Fisher ND, Jan Danser AH, Nussberger J, Dole WP, Hollenberg NK: Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans. Circulation 117: 3199-3205, 2008
    • (2008) Circulation , vol.117 , pp. 3199-3205
    • Fisher, N.D.1    Jan-Danser, A.H.2    Nussberger, J.3    Dole, W.P.4    Hollenberg, N.K.5
  • 12
    • 77950190399 scopus 로고    scopus 로고
    • Measurement of kidney perfusion by magnetic resonance imaging: Comparison of MRI with arterial spin labeling to para-aminohippuric acid plasma clearance in male subjects with metabolic syndrome
    • Ritt M, Janka R, Schneider MP, Martirosian P, Hornegger J, Bautz W, Uder M, Schmieder RE: Measurement of kidney perfusion by magnetic resonance imaging: comparison of MRI with arterial spin labeling to para-aminohippuric acid plasma clearance in male subjects with metabolic syndrome. Nephrol Dial Transplant 25: 1126-1133, 2010
    • (2010) Nephrol Dial Transplant , vol.25 , pp. 1126-1133
    • Ritt, M.1    Janka, R.2    Schneider, M.P.3    Martirosian, P.4    Hornegger, J.5    Bautz, W.6    Uder, M.7    Schmieder, R.E.8
  • 14
    • 59849101131 scopus 로고    scopus 로고
    • Aliskiren therapy will have minimal effect on in-tracellular renin of renin-producing cells
    • Campbell DJ: Aliskiren therapy will have minimal effect on in-tracellular renin of renin-producing cells. Hypertension 53: e17, 2009
    • (2009) Hypertension , vol.53
    • Campbell, D.J.1
  • 16
    • 69849112971 scopus 로고    scopus 로고
    • Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension
    • Andersen K, Weinberger MH, Constance CM, Ali MA, Jin J, Prescott MF, Keefe DL: Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension. J Renin Angiotensin Aldosterone Syst 10: 157-167, 2009
    • (2009) J Renin Angiotensin Aldosterone Syst , vol.10 , pp. 157-167
    • Andersen, K.1    Weinberger, M.H.2    Constance, C.M.3    Ali, M.A.4    Jin, J.5    Prescott, M.F.6    Keefe, D.L.7
  • 17
    • 9644287897 scopus 로고    scopus 로고
    • Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the an-giotensin II-renin feedback interruption
    • Azizi M, Ménard J, Bissery A, Guyenne TT, Bura-Riviére A, Vaidyanathan S, Camisasca RP: Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the an-giotensin II-renin feedback interruption. J Am Soc Nephrol 15: 3126-3133, 2004
    • (2004) J Am Soc Nephrol , vol.15 , pp. 3126-3133
    • Azizi, M.1    Ménard, J.2    Bissery, A.3    Guyenne, T.T.4    Bura-Riviére, A.5    Vaidyanathan, S.6    Camisasca, R.P.7
  • 20
    • 77954386389 scopus 로고    scopus 로고
    • Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study)
    • Kobori H, Urushihara M, Xu JH, Berenson GS, Navar LG: Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study). J Hypertens 28: 1422-1428, 2010
    • (2010) J Hypertens , vol.28 , pp. 1422-1428
    • Kobori, H.1    Urushihara, M.2    Xu, J.H.3    Berenson, G.S.4    Navar, L.G.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.